2018-11-13T10:38:13-06:00 2017-12-31 BDO USA LLP 32125 SOLON ROAD STE 200 SOLON OH 44139 990 2017-01-01 270486705 ALLIANCE FOR REGENERATIVE MEDICINE % THOMAS J DULA ALLI 2024192515 525 SECOND STREET NE WASHINGTON DC 20002 JANET LYNCH LAMBERT CEO 2024192515 2018-10-31 true Jacob Cook P01240455 4402488787 4.59.41.210 34986820183175000003 2018-11-13 P C7166AD04682B9F8980E46456EAB50843D73DF7E 7DE4C5056D55B9C117127BBF70C1431388240772 2017 2019-02-21 02:37:17Z JANET LYNCH LAMBERT 525 SECOND STREET NE WASHINGTON DC 20002 4015253 false X WWW.ALLIANCERM.ORG X 2009 DC SEE SCHEDULE O 31 31 0 485 0 7109 0 3564512 4015135 100 118 0 0 3571721 4015253 0 0 0 0 0 0 0 0 0 3410335 3712649 3410335 3712649 161386 302604 1349510 2053280 900438 1301604 449072 751676 X SEE SCHEDULE O false false 1492357 2044202 COMMUNICATIONS, CAPITAL FORMATION, AND OPERATIONS: TO DEVELOP PUBLICATIONS, SOCIAL MEDIA STRATEGIES, AND OTHER MATERIALS THAT WILL EDUCATE THE PUBLIC ABOUT REGENERATIVE MEDICINE. 1150797 1820933 POLICY, ADVOCACY, AND GOVERNMENT RELATIONS: TO PROVIDE MEETINGS AND WORKSHOPS THAT WILL ASSIST MEMBERS WITH GOVERNMENT RELATIONS AND REGULATORY DECISION MAKING. 468983 150000 SCIENCE AND TECHNOLOGY: TO DEVELOP CONSENSUS PRODUCT DEVELOPMENT AND REGULATORY STANDARDS, AND PROVIDE MORE EFFICIENT ACCESS TO INDUSTRY BEST-PRACTICES REGARDING MANUFACTURING AND SCALE-UP. 3112137 false false false true false false false false false true false false false false true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false true 25 0 true 0 false false false false true true false X 31 31 false true false false false true false true true false false false true true true false false false false false DC X THOMAS J DULA 7038551301 525 SECOND STREET NE WASHINGTON DC 20002 RAHUL ARAS TREASURER 1.15 0.0 X X 0 0 0 MARTHA ROOK SECRETARY 1.15 0.0 X X 0 0 0 BOB PRETI CHAIRMAN 1.73 0.0 X X 0 0 0 MATT PATTERSON VICE CHAIRMAN 1.44 0.0 X X 0 0 0 NESSAN BERMINGHAM DIRECTOR 0.15 0.0 X 0 0 0 DOUG DOERFLER DIRECTOR 0.38 0.0 X 0 0 0 EDUARDO BRAVO DIRECTOR 0.29 0.0 X 0 0 0 FLAGG FLANAGAN DIRECTOR 0.29 0.0 X 0 0 0 CHRISTIAN HOMSY DIRECTOR 0.04 0.0 X 0 0 0 OLIVIER DANOS DIRECTOR 0.04 0.0 X 0 0 0 DEBBIE DEAN DIRECTOR 0.15 0.0 X 0 0 0 DENA LADD DIRECTOR 0.15 0.0 X 0 0 0 MARTIN ANDREWS DIRECTOR 0.12 0.0 X 0 0 0 MICHAEL MAY DIRECTOR 0.29 0.0 X 0 0 0 ANDREA HUNT DIRECTOR 0.08 0.0 X 0 0 0 PAUL LAIKIND DIRECTOR 0.12 0.0 X 0 0 0 CLAUDIA ZYLBERBERG DIRECTOR 0.29 0.0 X 0 0 0 ISABELLE RIVIERE DIRECTOR 0.12 0.0 X 0 0 0 PHIL VANEK DIRECTOR 0.48 0.0 X 0 0 0 JAY SIEGEL DIRECTOR 0.19 0.0 X 0 0 0 GREG NAEVE DIRECTOR 0.08 0.0 X 0 0 0 DAVID SMITH DIRECTOR 0.12 0.0 X 0 0 0 TIM OLDHAM DIRECTOR 0.08 0.0 X 0 0 0 BYUNG GEON BG RHEE DIRECTOR 0.08 0.0 X 0 0 0 KEITH THOMPSON DIRECTOR 0.15 0.0 X 0 0 0 JASON WERTHEIM DIRECTOR 0.15 0.0 X 0 0 0 ALEXANDER VOS DIRECTOR 0.29 0.0 X 0 0 0 JEFF WALSH DIRECTOR 0.15 0.0 X 0 0 0 SUSAN WASHER DIRECTOR 0.29 0.0 X 0 0 0 ZAMI ABERMAN DIRECTOR 0.12 0.0 X 0 0 0 DONNA SKERRETT DIRECTOR 0.12 0.0 X 0 0 0 THOMAS J DULA CHIEF FINANCIAL OFFICER 6.0 0.0 X 52500 0 0 JANET LAMBERT CHIEF EXECUTIVE OFFICER 6.0 0.0 X 165173 0 0 217673 0 0 1 false true false ADJUVANT PARTNERS LLC 1340 SMITH AVE SUITE 200 BALTIMORE MD 21209 STAFFING SERVICES 1451437 HOLLAND KNIGHT LLP 800 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 STAFFING SERVICES 421869 ESTANCIA LA JOLLA HOTEL SPA 9700 NORTH TORREY PINES RD LA JOLLA CA 92037 EVENT SERVICES 244851 EXPERT SERVICE ADVICE ED VANDERVAERENSTRAAT 30A PO BOX 8 HOEILAART 0 BE 1560 MANAGEMENT SERVICES 153056 4 0 MEMBERSHIP DUES 900099 2194202 2194202 STEM CELL CONFERENCE 900099 1356388 1356388 MEMBERSHIP MEETINGS 900099 145076 145076 REGENMED INVESTOR MEETING 900099 319469 319469 4015135 118 118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4015253 4015135 118 0 0 0 0 0 0 0 0 0 0 375000 262500 112500 0 32472 0 32472 0 69711 991 68720 0 686229 686229 0 0 0 0 320420 249393 71027 0 37600 0 37600 0 27448 0 27448 0 0 62867 0 62867 0 25718 25718 0 0 0 0 0 0 1012375 1012375 0 0 0 0 421 0 421 0 19964 19964 0 0 EUROPEAN UNION SECTION 231480 207105 24375 MEMBERSHIP SUPPORT 220199 220199 STRATEGIC PRIORITY 212153 201609 10544 ADMIN./COMMITTEE SUPPORT 172521 96489 76032 206071 129565 76506 3712649 3112137 600512 0 433746 1066528 349000 397085 0 0 546555 581072 0 0 0 0 0 0 0 0 19225 1276 3130 811 984 2319 0 0 0 0 0 0 0 0 0 5000 1349510 2053280 93749 127067 0 0 806689 1174537 0 0 0 0 0 0 0 0 0 0 0 0 900438 1301604 X 449072 751676 0 0 0 0 449072 751676 1349510 2053280 302604 X false true X true false false false false 2194202 686229 -143894 542335 658261 -115926 0 3130 811 2319 2319 0 0 X 4015253 4015253 4015253 3712649 3712649 3712649 PART X, LINE 2: THE ALLIANCE IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE. INCOME TAXES ON UNRELATED BUSINESS INCOME, IF ANY, ARE PROVIDED AT THE APPLICABLE RATES ON INCOME FOR FINANCIAL REPORTING PURPOSES. THE ALLIANCE HAS ADOPTED THE ACCOUNTING GUIDANCE FOR UNCERTAINTY IN INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. AS THE DECEMBER 31, 2017 AND 2016, THE ALLIANCE HAD NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE ALLIANCE'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING ITS ACTIVITIES, THE ALLIANCE BELIEVES ITS POSTION ON TAX-EXEMPT STATUS IS CURRENT BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE ALLIANCE HAS ASSESSED THAT THERE ARE NO ACTIVTIES UNRELATED TO ITS PURPOSE AND, THEREFORE, NO TAX IS TO BE RECOGNIZED. IT IS THE POLICY OF THE ALLIANCE TO INCLUDE IN EXPENSES, PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE ARE NO PENALITES OR INTEREST FROM TAXING AUTHORITIES INCLUDED IN EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2017 AND 2016. false false false false false false false false false JANET LAMBERT CHIEF EXECUTIVE OFFICER 165173 165173 FORM 990, PART I, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART III, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART VI, LINE 3: ADJUVANT PARTNERS, LLC IS ENGAGED TO PROVIDE MANAGEMENT SERVICES FOR ALLIANCE FOR REGENERATIVE MEDICINE. FORM 990, PART VI, LINE 7A: THE GOVERNING BODY IS ELECTED BY THE MEMBERS AT THE ANNUAL MEETING THAT TAKES PLACE IN THE FALL EACH YEAR. FORM 990, PART VI, LINE 11B: THE TREASURER AND FINANCE COMMITTEE REVIEW THE TAX RETURN. FORM 990, PART VI, LINE 12C: THE CONFLICT OF INTEREST POLICY COVERS ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURE IS TO DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURES ARE REVIEWED AND MAINTAINED BY THE REMAINING MEMBERS OF THE GOVERNING BOARD OR COMMITTEE. THE GOVERNING BOARD OR COMMITTEE REVIEWS EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF POTENTIAL OR ACTUAL CONFLICTS (PAST, PRESENT, OR FUTURE) ARE IDENTIFIED, THE CHAIR PERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGENOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. THE IDENTIFIED CONFLICTS OF INTEREST AND APPROPRIATE RECUSALS ARE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.